{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 460779257
| IUPAC_name = (3''S'')-3-(4-bromophenyl)-''N'',''N''-dimethyl-3-pyridin-2-yl-propan-1-amine
| image = Dexbrompheniramine.svg
| width = 222

<!--Clinical data-->
| tradename = Drixoril, Conex, Dixaphedrine
| Drugs.com = {{drugs.com|MTM|dexbrompheniramine}}
| MedlinePlus = 
| pregnancy_US = C
| legal_US = OTC
| legal_CA = OTC
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life = 25 hours

<!--Identifiers-->
| IUPHAR_ligand = 7588
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 132-21-8
| ATC_prefix = R06
| ATC_suffix = AB06
| ATC_supplemental =  
| PubChem = 16960
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00405
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 16068
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 75T64B71RP
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 59269
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1201287

<!--Chemical data-->
| C=16 | H=19 | Br=1 | N=2
| molecular_weight = 319.24 g/mol
| smiles = Brc1ccc(cc1)[C@@H](c2ncccc2)CCN(C)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C16H19BrN2/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13/h3-9,11,15H,10,12H2,1-2H3/t15-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = ZDIGNSYAACHWNL-HNNXBMFYSA-N
}}

'''Dexbrompheniramine''' is an [[antihistamine]] with [[anticholinergic]] properties<ref>{{Cite journal 
| last1 = Löfkvist | first1 = T. 
| title = A comparative evaluation of oral decongestants in the treatment of vasomotor rhinitis 
| journal = The Journal of international medical research 
| volume = 6 
| issue = 1 
| pages = 56–60 
| year = 1978 
| pmid = 627306
| doi = 10.1177/030006057800600110 
}}</ref> used to treat [[allergy|allergic]] conditions such as [[hay fever]] or [[urticaria]]. It is the pharmacologically active dextrorotatory isomer of [[brompheniramine]]. It was formerly marketed in combination with [[pseudoephedrine]] under the name [[Drixoral]] in the US and Canada.

Dexbrompheniramine is a first generation antihistamine that reduces the effects of the [[neurotransmitter]] [[histamine]] in the body; sneezing, itching, watery eyes, and runny nose. 

==   Interactions  ==
MAO inhibitors within 14 days. MAO inhibitors include isocarboxazid, linezolid, phenelzine, rasagiline, selegiline, and tranylcypromine.

Potassium (Cytra, Epiklor, K-Lyte, K-Phos, Kaon, Klor-Con, Polycitra, Urocit-K).

Drinking alcohol can increase side effects of dexbrompheniramine.

== References ==
{{Reflist}}

{{Antihistamines}}
{{Cholinergics}}
{{Histaminergics}}

[[Category:Amines]]
[[Category:Enantiopure drugs]]
[[Category:H1 receptor antagonists]]
[[Category:Organobromides]]
[[Category:Pyridines]]

{{respiratory-system-drug-stub}}